SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 246 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $253,000 | -13.9% | 9,212 | +3.8% | 0.01% | -11.1% |
| Q2 2019 | $294,000 | -5.5% | 8,876 | 0.0% | 0.01% | -10.0% |
| Q1 2019 | $311,000 | +5.4% | 8,876 | 0.0% | 0.01% | -9.1% |
| Q4 2018 | $295,000 | -34.0% | 8,876 | 0.0% | 0.01% | -21.4% |
| Q3 2018 | $447,000 | +3.0% | 8,876 | +22.4% | 0.01% | 0.0% |
| Q2 2018 | $434,000 | +30.7% | 7,252 | 0.0% | 0.01% | +27.3% |
| Q1 2018 | $332,000 | +19.9% | 7,252 | +4.4% | 0.01% | +22.2% |
| Q4 2017 | $277,000 | +26.5% | 6,944 | +26.5% | 0.01% | +12.5% |
| Q3 2017 | $219,000 | +6.8% | 5,488 | +15.3% | 0.01% | 0.0% |
| Q2 2017 | $205,000 | +159.5% | 4,760 | +88.9% | 0.01% | +166.7% |
| Q1 2017 | $79,000 | +38.6% | 2,520 | +11.1% | 0.00% | 0.0% |
| Q4 2016 | $57,000 | – | 2,268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |